Impact of VKORC1, CYP4F2 and NQO1 gene variants on warfarin dose requirement in Han Chinese patients with catheter ablation for atrial fibrillation

BMC Cardiovascular Disorders
Jiao LiKaijun Cui

Abstract

The anticoagulation of atrial fibrillation catheter ablation during the perioperative stage does matter and should be treated with discretion. We aimed to assess impact of three important genes participating in vitamin K cycle (i.e. VKORC1 rs9923231, CYP4F2 rs2108622 and NQO1 rs1800566) on the daily stable warfarin dose requirement in Sichuan Han Chinese patients with catheter ablation of atrial fibrillation. A total of 222 atrial fibrillation patients taking stable warfarin therapy after catheter ablation operation were enrolled in this study. The study population included had high (≥2) risk according to the CHA2DS2-VASc risk score. Genotypes of VKORC1 rs9923231, CYP4F2 rs2108622 and NQO1 rs1800566 were analyzed by using the polymerase chain reaction restriction fragment length polymorphism method (PCR-RFLP). Multiple linear regression analysis was applied to depict the impact of VKORC1 rs9923231, CYP4F2 rs2108622 and NQO1 rs1800566 on the daily stable warfarin dose requirement. Carriers of VKORC1 rs9923231 AG/GG genotypes required significantly higher warfarin dose (3.03 ± 0.28 mg/day, 7.19 mg/day, respectively) than AA carriers (2.52 ± 0.07 mg/day; P < 0.001). Carriers of CYP4F2 rs2108622 CT/TT genotypes required significant...Continue Reading

References

Apr 29, 1998·The Journal of Biological Chemistry·V RadjendiraneA K Jaiswal
May 11, 2005·The Pharmacogenomics Journal·M WadeliusP Deloukas
May 17, 2006·Basic & Clinical Pharmacology & Toxicology·Claire Larramendy-GozaloLaurent Becquemont
Jul 11, 2007·Archives of Internal Medicine·Diane K WysowskiLynette Swartz
Nov 24, 2007·Pharmacogenomics·Kathryn M MomaryLarisa H Cavallari
Feb 26, 2010·Clinical Pharmacology and Therapeutics·J A PeriniG Suarez-Kurtz
Nov 19, 2010·Drug Metabolism and Pharmacokinetics·Onkar SinghBalram Chowbay
Jan 18, 2011·Blood·Jian-Ke TieDarrel W Stafford
Sep 11, 2013·European Journal of Clinical Pharmacology·Dhakchinamoorthi Krishna KumarChandrasekaran Adithan
Nov 20, 2015·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Xiaojuan YanJianqiang Ding

❮ Previous
Next ❯

Citations

Aug 30, 2020·Clinical and Translational Science·Nihal El RoubyLarisa H Cavallari
May 8, 2021·Journal of Cardiovascular Pharmacology·Qingqing XuShengying Qin
Oct 2, 2021·European Journal of Clinical Pharmacology·Xiaotong XiaJinhua Zhang

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
Genotyping

Software Mentioned

SPSS

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.